Resistance to Cancer Treatment: The Role of Somatic Genetic Events and the Challenges for Targeted Therapies
Therapeutic resistance remains a major cause of cancer-related deaths. Resistance can occur from the outset of treatment or as an acquired phenomenon after an initial clinical response. Therapeutic resistance is an almost universal phenomenon in the treatment of metastatic cancers. The advent of mol...
Main Authors: | Batist, Gerald, Wu, Jian Hui, Spatz, Alan, Miller, Wilson H., Cocolakis, Eftihia, Rousseau, Caroline, Diaz, Zuanel, Ferrario, Cristiano, Basik, Mark |
---|---|
Format: | Online |
Language: | English |
Published: |
Frontiers Research Foundation
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186943/ |
Similar Items
-
Physician Recruitment of Patients to Non-Therapeutic Oncology Clinical Trials: Ethics Revisited
by: Black, Lee, et al.
Published: (2013) -
The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML)
by: Assouline, Sarit, et al.
Published: (2012) -
Recruiting Terminally Ill Patients into Non-Therapeutic Oncology Studies: views of Health Professionals
by: Kleiderman, Erika, et al.
Published: (2012) -
Immune biomarker correlates from a Phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM)
by: Lapointe, Réjean, et al.
Published: (2015) -
Rapid modeling of cooperating genetic events in cancer through somatic genome editing
by: Sánchez-Rivera, Francisco J., et al.
Published: (2014)